Percutaneous Mitral Valve Repair in Cardiac Amyloidosis and Severe Mitral Regurgitation
Copyright © 2021 Elsevier Inc. All rights reserved..
Amyloidosis is an infiltrative disease with severe impact on the cardiac anatomy resulting in structural changes1. Mitral valve insult from the infiltrative process, although rare, has been known to cause severe mitral regurgitation4. Due to underlying comorbidities these patients may not be surgical candidates.17,18,19,20 The role of percutaneous mitral valve repair in cardiac amyloidosis has been described in a few prior cases.4,15 We review the epidemiology, diagnosis, and treatment of cardiac amyloidosis. We also highlight prior cases described in the literature of cardiac amyloidosis and severe mitral regurgitation, while discussing the role of percutaneous mitral valve repair in these patients.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:47 |
|---|---|
| Enthalten in: |
Current problems in cardiology - 47(2022), 9 vom: 15. Sept., Seite 100881 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Thakker, Ravi A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 09.08.2022 Date Revised 09.08.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.cpcardiol.2021.100881 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM326269517 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM326269517 | ||
| 003 | DE-627 | ||
| 005 | 20231225194229.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.cpcardiol.2021.100881 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1087.xml |
| 035 | |a (DE-627)NLM326269517 | ||
| 035 | |a (NLM)34078542 | ||
| 035 | |a (PII)S0146-2806(21)00096-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Thakker, Ravi A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Percutaneous Mitral Valve Repair in Cardiac Amyloidosis and Severe Mitral Regurgitation |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.08.2022 | ||
| 500 | |a Date Revised 09.08.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 Elsevier Inc. All rights reserved. | ||
| 520 | |a Amyloidosis is an infiltrative disease with severe impact on the cardiac anatomy resulting in structural changes1. Mitral valve insult from the infiltrative process, although rare, has been known to cause severe mitral regurgitation4. Due to underlying comorbidities these patients may not be surgical candidates.17,18,19,20 The role of percutaneous mitral valve repair in cardiac amyloidosis has been described in a few prior cases.4,15 We review the epidemiology, diagnosis, and treatment of cardiac amyloidosis. We also highlight prior cases described in the literature of cardiac amyloidosis and severe mitral regurgitation, while discussing the role of percutaneous mitral valve repair in these patients | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 700 | 1 | |a Elbadawi, Ayman |e verfasserin |4 aut | |
| 700 | 1 | |a Albaeni, Aiham |e verfasserin |4 aut | |
| 700 | 1 | |a Hasan, Syed Mustajab |e verfasserin |4 aut | |
| 700 | 1 | |a Suthar, Krishna H |e verfasserin |4 aut | |
| 700 | 1 | |a Modi, Shreyas A |e verfasserin |4 aut | |
| 700 | 1 | |a Berbarie, Rafic F |e verfasserin |4 aut | |
| 700 | 1 | |a Khalife, Wissam |e verfasserin |4 aut | |
| 700 | 1 | |a Chatila, Khaled F |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current problems in cardiology |d 1993 |g 47(2022), 9 vom: 15. Sept., Seite 100881 |w (DE-627)NLM000219622 |x 1535-6280 |7 nnns |
| 773 | 1 | 8 | |g volume:47 |g year:2022 |g number:9 |g day:15 |g month:09 |g pages:100881 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.cpcardiol.2021.100881 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 47 |j 2022 |e 9 |b 15 |c 09 |h 100881 | ||